Literature DB >> 3197346

The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage.

E F Wijdicks1, M Vermeulen, P van Brummelen, J van Gijn.   

Abstract

In order to prevent hypovolemia fludrocortisone acetate treatment was started on admission in 39 consecutive patients with CT evidence of subarachnoid hemorrhage. In 28 patients an aneurysm was proven or probable, and in 21 of these the effects of fludrocortisone acetate on sodium balance and on plasma volume could be studied. In the first five days plasma volume decreased more than 10% in four patients, decreased less than 10% in five and increased in 12. The cumulative sodium balance measured over five days was negative in seven of the 21 patients. Plasma renin values were measured in 15 of the 21 patients and also in stored samples of 18 patients who were not treated with fludrocortisone acetate. Plasma renin values were less high in patients treated with fludrocortisone acetate, regardless of the presence of a negative sodium balance. In three of the 39 patients signs of pulmonary edema developed, and low serum potassium values were observed in four of the 21 patients. In comparison with previous studies, these findings suggest that fludrocortisone acetate is an effective method of decreasing the incidence of volume depletion and negative sodium balance.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3197346     DOI: 10.1016/0303-8467(88)90023-6

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  9 in total

Review 1.  Management of hyponatremia and volume contraction.

Authors:  Alejandro A Rabinstein; Nicolas Bruder
Journal:  Neurocrit Care       Date:  2011-09       Impact factor: 3.210

Review 2.  Novel treatment targets for cerebral edema.

Authors:  Brian P Walcott; Kristopher T Kahle; J Marc Simard
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Specialized neurocritical care, severity grade, and outcome of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Corinne Lerch; Yasuhiro Yonekawa; Carl Muroi; Miroslava Bjeljac; Emanuela Keller
Journal:  Neurocrit Care       Date:  2006       Impact factor: 3.210

Review 4.  Update on subarachnoid haemorrhage.

Authors:  José M Ferro; P Canhão; R Peralta
Journal:  J Neurol       Date:  2008-03-25       Impact factor: 4.849

Review 5.  Hyponatremia and brain injury: historical and contemporary perspectives.

Authors:  Matthew A Kirkman; Angelique F Albert; Ahmed Ibrahim; Doris Doberenz
Journal:  Neurocrit Care       Date:  2013-06       Impact factor: 3.210

6.  Conivaptan bolus dosing for the correction of hyponatremia in the neurointensive care unit.

Authors:  Theresa Murphy; Rajat Dhar; Michael Diringer
Journal:  Neurocrit Care       Date:  2009-01-04       Impact factor: 3.210

Review 7.  Management of aneurysmal subarachnoid hemorrhage.

Authors:  Michael N Diringer
Journal:  Crit Care Med       Date:  2009-02       Impact factor: 7.598

8.  Safety and Efficacy of Fludrocortisone in the Treatment of Cerebral Salt Wasting in Patients With Tuberculous Meningitis: A Randomized Clinical Trial.

Authors:  Usha K Misra; Jayantee Kalita; Mritunjai Kumar
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 9.  Syndrome of inappropriate antidiuretic hormone secretion and cerebral/renal salt wasting syndrome: similarities and differences.

Authors:  Ji Young Oh; Jae Il Shin
Journal:  Front Pediatr       Date:  2015-01-22       Impact factor: 3.418

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.